United States · FDA National Drug Code directory
Topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-868_8dde15e5-8f0f-43bd-847f-08f5c015e4a1
- Product NDC
- 67877-868
- Form
- CAPSULE
- Composition / generic term
- Topiramate
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240805
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (67877-868-05) · 67877-868-05
- 1 BLISTER PACK in 1 CARTON (67877-868-33) / 10 CAPSULE in 1 BLISTER PACK · 67877-868-33
- 60 CAPSULE in 1 BOTTLE (67877-868-60) · 67877-868-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →